Scientific Basis of Vaccines Flashcards

1
Q

Describe the relation between smallpox and cowpox

A
  1. Smallpox virus (variola virus)
  2. Milkmaids that had cowpox never got smallpox and could not be variolated
  3. Variola caused smallpox
  4. If you inoculated someone with a lesion from someone who was recovering from smallpox, they would recover
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define Variolation

A

Variolation is inoculation with materials from infected individual (pus).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe jenners observed principles

A
  1. Challenge dose – proves protection from infection. Proves that the vaccine is working.
  2. Concept of attenuation  something weakened may give you protection
  3. Concept that prior exposure to agent boosts protective response
  4. Cross-species protection – antigenic similarity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How and why was smallpox eradicated?

A

How?

  1. Vaccination programmes
  2. case finding (surveillance) and movement control

Why possible?

  1. No sub-clinical infections
  2. After recovery, the virus was eliminated - no carrier states
  3. No animal reservoir
  4. Effective vaccine (live vaccinia virus)
  5. Slow spread, poor transmission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define vacccine

What does it produce?

Does it prevent disease?

What does it lead to?

A

Vaccine: material from an organism that will actively enhanced adaptive immunity.
• It produces an immunologically primed state that allows of a rapid secondary immune response on exposure to an antigen
• Its prevents disease but not infection
• Long lasting – requires immunological memory
• Leads to T-cell memory or antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the rationale behind vaccines

A
  • Protects the individual by reducing rate and severity.
  • Protects population through herd immunity.
  • Eradicates the disease.
  • Take into account reservoirs of infection and vaccine uptake rate.
  • Balance risk to individual against risk to population.
  • Prevention of epidemics.
  • Rubella is a mild disease to vaccine is not to protect population but to prevent congenital damage.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the vaccine paradox

A
  • Herd immunity- memory boosted by periodic outbreaks of disease in the community.
  • As rates of disease decline, there is no natural boosting.
  • This then increases the importance of vaccination take up rates.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the two types of immunity?

A
  • Active- natural exposure, infection or vaccination and has long-term effect.
  • Passive- naturally acquire antibodies through placenta/breastmilk. Due to prophylaxis and/or treatment. Short effect.
  • In first world war, horse anti-tetanus sera was used to treat soldiers with wound infections reduced mortality by x30.
  • Post exposure protection in rabies- incubation is 30 days so can build immunity through vaccination before infection takes hold. Few prophylaxis vaccines available.
  • Pooled human immune sera (passive) with high antibody titre against varicella-zoster virus (chicken pox) in vulnerable (neonates).
  • Hypogammaglobulinemia: keep infection free with pooled normal human IgG.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the immune response to an antigen

A

On image

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the general principles of vaccines

A
  • Induce correct type of response (antibodies needed for polio, cell mediated for tuberculosis).
  • Induce response in right place- mucosal- secretory IgA (flu/polio), systematic (yellow fever).
  • Parenteral vaccines give poor mucosal immunity.
  • Oral vaccines processed by MALT so good IgA.
  • Duration of protection- short-term (travel)- antibody is sufficient, long-term- memory is essential.
  • Boosters- natural (seasonal epidemics, carriage) or vaccines.
  • Type of infection- long incubation time (systematic- measles) or short incubation time (surface- cholera).
  • Difficult to induce long-lasting immunity at mucosal surfaces.
  • Age of vaccination- maternal antibodies in neonate sIgA in milk lasts 6 months.
  • Problem for live attenuated vaccines (e.g. MMR). Virus is neutralised by maternal antibody so no acquired protection .
  • Vaccinate after 9 months but many babies already infected by then in endemic areas.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the nature of antigens

Can serology be used to differentiate between antigens?

A
  • Monotypic (only get once)/polytypic (can get multiple times)- antigen variation and genetic diversity. E.g. measles (monotypic) , flu and gonorrhoea (polytypic).
  • Most antigens are immunogenic but not immune-protective as they can’t predict.
  • Serology can differentiate exposure from vaccination. E.g. Hep B- viral surface antigen.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can bacterial toxins be used as vaccines?

A

Inactivation with formaldehyde to form toxoid (antigenic and non-toxic).

Initiates antibody production and immunity with no tissue damage or disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are capsular polysaccharides

A

Poor antigens as short term memory, no T cell immunity, less immunogenic in children under 3, poor IgG2 responses, which would promote opsonisation and major recognition of polysaccharides, also B cells less mature.

Enhance immunogenicity by protein conjugation i.e, toxoids + outer membrane proteins to get long-lasting immunity and response in children. E.g. MenC/Hib vac.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does conjugation work?

A

Link polysaccharide antigen to protein carrier that the infant immune system already recognises to provoke an immune response.

Polysaccharide binds BCR and won’t produce a lot of antibody- poor memory in children.

Once conjugated, b cell will activate T cell which will in turn activate B cell through CD4 to increase antibody count against antigen as it is also being recognised by the B cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are Vaccine Adjuvants?

What 3 things do they do?

A
  • Chemicals or lipid structures that enhance immune response using vaccine components (e.g. aluminium salts and lipids- trap antibody’s in vaccine so not cleared as well/quickly so it stays in circulation longer).
  • Without, immune response is much lower and not well maintained.
  • Enhance immune response to antigen.
  • Promote uptake and antigen presentation.
  • Stimulate correct cytokine profiles.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe:

Type 1

Type 2

Type 3

vaccines

A

Types of Vaccines I
One or more components of a microorganism
1. Live, attenuated organism

  • (e.g. BCG, polio(Sabin), MMR, yellow fever, VZV )
  • by:- serial passage,
  • low temperature adaptation,
  • recombinant genetics ( S.typhi Ty21a; galE + aroA/B/C mutant)
  • selection of natural attenuated strains
  • BCG for TB  given to new born babies in areas of high TB prevalence
  • Some polio vaccines reverted to virulent strains again
  • BCG and MMR are the ones to remember
  • Polio (Sabin) Type 1 has 57 mutations;
  • Type 2 & 3 only a few.
  • Possible to revert (wild-type in nappies!)

• 3 separate doses to overcome strain antagonism and ensure adequate immune response against each type

Types of Vaccines 2
Killed, whole organism
• e.g. pertussis, flu (old type), polio (Salk type), cholera, HepA
• reactogenicity
• boosting required
• It can induce the right kind of immunity
• It is the polio vaccine that we now use
• You need to have boasting.

  1. Sub-unit vaccines (individual components)
    • proteins
    • toxoids (diphtheria; tetanus)
    • peptides (synthetic)
    • polysaccharide - poor antigens and conjugated to toxoid + outer membrane protein (e.g. MenC; Hib;)
    • recombinant proteins
    • sub-cellular fractions
    • surface antigens e.g. Hepatitis B; influenza haemagglutinins; menB
    • virulence determinant e.g. aP-pertussis:- adhesin + toxoid + OMP (outer membrane protein)  this one used for whooping cough
  • When you identify components of an organism that give good immunity
  • They are a sub part of the organism.
  • Have to conjugate polysaccahrides to make conjugated polysaccharide vaccines
  • Some vaccines are made from recombinant proteins.